Merged platform Suvoda combines Greenphire capabilities with its own platform into a unified clinical trial technology stack, presenting a single integration point for sponsors, sites, and patients. Sales opportunity: target customers seeking a consolidated solution for RTSM, eConsent, eCOA, patient payments, and travel, reducing vendor fragmentation.

AI driven Recent announcements highlight AI capabilities and Sofia AI assistant, plus platform releases that unify data and operations. Sales angle: emphasize AI-assisted trial management to accelerate study startup, optimize data quality, and enhance patient engagement.

Industry focus Strong emphasis on oncology, CNS, and rare diseases with services spanning study data, patient engagement, and operations. Opportunity: target sponsors in high-need therapeutic areas that require complex trial management and patient-centric solutions.

Awards credibility Multiple industry recognitions for patient relationship management and trial participation experiences bolster credibility with potential clients. Use as proof points in outreach to establish trust and differentiate from competitors.

Operational efficiency Agentic RTSM claims to reduce startup timelines by up to 80%, signaling clear value in speed-to-first-patient and overall trial timelines. Sales focus: prioritize CROs and sponsors aiming to shorten timelines and reduce operational bottlenecks with a proven efficiency advantage.